Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation

The biologic medication filgrastim is approved by the Food and Drug Administration (FDA) to mobilize hematopoietic progenitor cells (HPCs) for collection by leukapheresis for autologous hematopoietic stem cell transplant (HSCT). The FDA-approved biologic tbo-filgrastim is currently used off-label fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Eplin, Dwight D., Jackson, Anna D., Smith, Austin M., Salvig, Brent, Chinratanalab, Wichai, Savani, Bipin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432370/
https://www.ncbi.nlm.nih.gov/pubmed/34595434
http://dx.doi.org/10.2991/chi.d.191008.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432370/
https://www.ncbi.nlm.nih.gov/pubmed/34595434
http://dx.doi.org/10.2991/chi.d.191008.001

Ejemplares similares